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ABSTRACT: In the context of anemias, it is estimated that 
its prevalence in Brazil and in the world is around 30%, which 
is higher than regarded as acceptable by the World Health 
Organization. Due to the lack of official Brazilian records on the 
epidemiological distribution of the disease, this study aims to 
demonstrate the prevalence of anemia in a private hematology 
outpatient clinic, and to verify its distribution in terms of sex, 
age, severity, and etiology. Thus, it was performed a cross-
sectional descriptive analysis, with secondary data collection, 
of the medical records of patients in their first consultation of a 
hematology outpatient clinic in the private sector of Campinas/
SP. A total of 1422 patients were selected, 456 diagnosed with 
anemia (32%), with a predominant age range between 40-49 
years (21.7%), and with women representing 77% of the sample. 
In the evaluation of blood counts, the mean hemoglobin was 
10.52 g/dL, in most cases being normocytic and mild anemias. 
Regarding the etiology, 62.7% of the sample had iron deficiency 
anemia, and of this, 78.7% were of hemorrhagic origin. The 
second most prevalent cause was anemia of inflammation 
(14.4%). In view of the results obtained, it was possible to draw 
an epidemiological profile of anemia in the referred clinic, with 
people with anemia being mostly women of childbearing age, 
with mild and microcytic anemia; and infer that, in most cases, 
anemia is a preventable disease, making it possible to decrease 
its prevalence.
Keywords: Anemia; Prevalence; Epidemiology.
RESUMO: No contexto das anemias, estima-se que sua 
prevalência no Brasil e no mundo seja em torno de 30%, 
acima do esperado como aceitável pela Organização Mundial 
da Saúde. Devido a carência de registros oficiais brasileiros 
sobre a distribuição epidemiológica da doença, esse estudo tem 
como objetivo demonstrar a prevalência de anemias em um 
ambulatório de hematologia do sistema privado, e verificar sua 
distribuição quanto ao sexo, idade, gravidade e etiologia. Assim, 
foi feita uma análise transversal descritiva, com coleta de dados 
secundários, dos prontuários de pacientes em primeira consulta 
de um ambulatório de hematologia da rede privada de Campinas/
SP. Foram selecionados 1422 pacientes, sendo 456 diagnosticados 
com anemia (32%), de faixa etária predominante entre 40-49 
anos (21,7%), e com mulheres ocupando 77% da amostra. Na 
avaliação dos hemogramas, a média de hemoglobina foi de 10,52 
g/dL, sendo na maioria dos casos anemias normocíticas e leves. 
Em relação à etiologia, 62,7% da amostra era ferropênica, e desta, 
78,7% de origem hemorrágica. A segunda causa mais prevalente 
foi a anemia da inflamação (14,4%). Diante dos resultados obtidos, 
foi possível traçar um perfil epidemiológico da anemia no referido 
ambulatório, sendo que os anêmicos são em sua maioria mulheres 
em idade fértil, com anemia leve e microcítica, e inferir que, em 
grande parte dos casos, a anemia é uma doença evitável, tornando 
possível a diminuição de sua prevalência.
Palavras-chave: Anemia; Prevalência; Epidemiologia.
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INTRODUCTION
Anemia is a public health problem that is still neglected worldwide1-6. With prevalence 
figures of around 30% worldwide7, it is a topic that is rarely 
addressed in medical discussions.
According to the World Health Organization 
(WHO), in 2010, more than two billion people were 
anemic, which corresponds to almost a third of the world’s 
population (32.9%)7,8,9. Preschoolers, women, especially 
those of childbearing age, and the elderly are at risk for 
anemia10,11,12. Also according to the WHO, anemia is defined 
as “low hemoglobin concentration”8,10,11,13,14. The causes for 
this situation vary, such as: nutritional deficiencies, blood 
loss, early destruction of red blood cells in the bloodstream, 
inflammatory diseases and renal failure4,7,10,11,15,16. The WHO 
criteria for diagnosing anemia is hemoglobin below 13 g/
dL in men and below 12 g/dL in women1,6,11,14,16.
Another relevant data is the mean corpuscular 
volume (MCV), because using it makes it possible to 
classify anemia into microcytic (low MCV), normocytic 
(normal MCV) and macrocytic (high MCV), thus one 
can establish clinical reasoning regarding the most likely 
etiologies, since there is a correlation between such values 
and the causes of anemia11.
According to WHO recommendations, the 
population significance of the prevalence of anemia is 
classified as normal or acceptable (below 5% of anemics in 
relation to the total population), mild (5 to 19.9%), moderate 
(20 to 39.9%) and severe (greater than or equal to 40%)2. 
Another classification instituted by that same Organization 
considers the severity of anemia: mild (hemoglobin above 
10 g/dL), moderate (hemoglobin between 8 and 10 g/dL) 
and severe (hemoglobin below 8 g/dL)4.
The Pan-American Health Organization states that 
Brazil is in second place among the countries of Latin 
America and the Caribbean with the highest prevalence 
of anemic patients (30%); only Peru has higher numbers 
(57%)8,17. According to the Brazilian Ministry of Health, 
in 2006, the general estimate of the prevalence of anemia 
in the country is 25-30%18. In Brazil there is no official 
record of prevalence of the disease, there are only regional 
studies10,13,15.
Among the causes of anemia, iron deficiency is the 
most common12,17,19,20, responsible for 50% of cases5,6,8. 
In developing countries such as Brazil, diet is essential 
in the onset of iron deficiency anemia13, mainly because 
iron, although present in cereals and legumes (foods 
that are easier to access), is in its low availability9,19. 
Therefore, in risk groups, it is necessary to stimulate the 
consumption of animal iron, its active form, in order to 
prevent the most prevalent cause of anemia. Currently, iron 
deficiency in Brazil is more found than other deficiencies, 
such as hypovitaminosis A, primary iodine deficiency and 
protein-energy malnutrition21. However, iron deficiency 
can also result from blood loss. While menstrual loss 
is the major non-nutritional cause of iron deficiency in 
women of childbearing age, in men and postmenopausal 
women bleeding from the gastrointestinal tract is the most 
common cause19.
As a differential diagnosis of iron deficiency anemia, 
it is important to mention hemoglobinopathies22, whose 
main examples are thalassemia and sickle cell anemia. 
Another fundamental concept is anemia of inflammation, 
formerly called anemia of chronic disease, also considered 
a differential diagnosis of iron deficiency anemia23. It is 
known that there is a blockage in the use of iron promoted 
by the interaction of inflammatory cytokines with hepcidin, 
which leads to a functional decrease in iron, followed by 
anemia. This mechanism can be triggered by autoimmune 
diseases, infections, obesity, neoplasms and chronic 
diseases23.
With the decrease in hemoglobin, regardless of 
the etiology, there is less tissue oxygenation5,6,24 so an 
individual with anemia may have his or her mental and 
psychomotor development impaired3,12, in addition to 
presenting a decrease in performance of work and quality 
of life4,6,25. In 1990, there was a meeting organized by the 
United Nations, and at that time, goals were drawn up to 
reduce the prevalence of anemia in the world, but until 
today it has not been possible to achieve the objectives set21. 
Therefore, the control of anemia is a global challenge18 and 
everyone’s effort is needed to control this problem.
OBJECTIVE
This article aims to: 1) demonstrate the prevalence 
of anemia in patients seen at Clínica Medeiros, a 
hematology outpatient clinic in the private health sector in 
Campinas/SP, and 2) verify the distribution of this disease, 
according to sex, age and severity, and its most common 
etiologies.
METHOD
This is a cross-sectional descriptive study, with 
secondary data collection. The electronic medical records 
(filed in the Doctor’s Office 2014 program - review 2 
DO130814-6966/1) of all patients who registered their first 
consultation at Clínica Medeiros hematology outpatient 
clinic from September 2014 to September 2017 were 
analyzed.
The patients were all seen by the same professional 
and the data collected, also by only one person, related 
to anamnesis: sex, age, reason for the consultation; and 
complementary exams: hemoglobin value (in g/dL, being 
considered anemic men with values below 13 g/dL and 
women below 12 g/dL), MCV (in phentoliters - fL, being 
the red blood cell microcytic when below 82 fL, normocytic 
when between 82 and 98 fL, and macrocytic when above 
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98 fL), ferritin value (being considered iron deficiency 
when below 30 ng/mL), vitamin B12 (low when less than 
200 pg/mL), folic acid (decreased when below 3.5 ng/ml), 
reticulocyte screening, lactic dehydrogenase and indirect 
bilirubin when necessary to assess hemolysis (considered 
normal at 0.5-1.5%, less than 400U/L and up to 0.8 mg/
dL, respectively) and interpretation of bone marrow biopsy 
when necessary to search for bone marrow diseases in cases 
of anemia of a cause not explained by the routine laboratory 
tests mentioned above. The WHO criteria for the severity 
of anemia in terms of hemoglobin value was also adopted: 
if it is above 10g/dL, it is mild; if between 8 and 10 g/dL, 
it is moderate; and if below 8 g/dL, it is severe.
In this clinic, only patients from the age of 14 and 
above are admitted, so we did not have any data from the 
pediatric age group. We considered women of childbearing 
age from 14 to 49 years old, and elderly people over 65 
years old.
The study included all patients who registered 
their first visit in the period above and who had anemia, 
according to the hemoglobin criteria of anemia. We 
excluded those without clinical or laboratory findings of 
anemia in the first visit.
This study was approved by the Institutional 
Ethics Committee, under number 4.284.932, CAAE 
35401220.5.0000.5374.
RESULTS
A total of 1422 patients registered their first visit 
during the study period. According to their main diagnoses, 
423 patients were found to have anemia as the main 
diagnosis. In addition, we found 33 individuals who had 
other main diagnoses, but also had anemia in their first visit. 
The total number of patients for both groups together was 
456, 32% of the total - prevalence of anemia in this study 
and this sample was studied.
During assessment, anemic patients were distributed 
according to age: 16 under 20 years old, 49 between 20-29 
years old, 90 between 30-39 years old, 99 between 40-49 
years old, 64 between 50-59 years old, 38 between 60-69 
years old, 49 between 70-79 years old, 41 between 80-89 
years old and 10 over 89 years old.
It was found that 353 (77%) of the anemic patients 
were women, and most of the 456 individuals were in the 
40-49 age group (99 patients = 21.7%). Regarding the 
evaluated complementary tests, about the blood count of 
patients with anemia, we found the following distribution 
of hemoglobin (Table 1). As for MCV, there were 221 
patients with microcytic anemia, 212 with normocytic and 
23 with macrocytic.













Mean 10.52 10.4 10.92 10.72 10.44 11.23
Maximum 12.9 11.9 12.9 12.9 11.9 12.9
Minimum 5.5 5.5 6.0 6.7 6.7 6.8
Considering the severity of anemia according to the 
hemoglobin value, we found that most patients had mild 
anemia (306 individuals, 67.1%), while moderate anemia 
affected 122 people and severe anemia only 28 patients.
As for the etiologies of anemia of the evaluated 
patients, we obtained the following distribution (Figure 1).
Abbreviation: CRF (chronic renal failure)
Figura 1: Distribution of the causes of 
anemia of the evaluated patients (in absolute 
numbers) 
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We assessed that the mean age of anemic individuals 
in general was 50.71 years old, being 48 years old for 
women and 60 years old for men (Table 2). The age groups 
most affected in women were the 30-39 years old and the 
40-49 years old, both with 23.5% of cases. In men, the age 
groups most affected were the 50-59 years old and the 70-79 
years old, both with 17.5% of cases (Table 2).
Table 2: Distribution of anemics, according to sex and age - n (%)
Women Men Total
Mean age 48 y-o 60 y-o
<20 years old (y-o) 14 (4) 2 (1.9) 16 (3,5)
20-29 y-o 41 (11.6) 8 (7.7) 49 (10,7)
30-39 y-o 83 (23.5) 7 (6.8) 90 (19,8)
40-49 y-o 83 (23.5) 16 (15.5) 99 (21,7)
50-59 y-o 46 (13) 18 (17.5) 64 (14,1)
60-69 y-o 23 (6.5) 15 (14.6) 38 (8,3)
70-79 y-o 31 (88) 18 (17.5) 49 (10,7)
80-89 y-o 27 (7.7) 14 (13.6) 41 (9)
>89 y-o 5 (1.4) 5 (4.9) 10 (2,2)
Total 353 (77) 103 (23) 456
Among the risk groups of women, women of 
childbearing age and the elderly, we had an anemia 
prevalence of 36.3%, 36.3% and 43.9%, respectively 
(Table 3). Of the total anemic patients (456), 77% were 
women, 48.5% were women of childbearing age and 25.9% 
were elderly. The mean hemoglobin in women, women of 
childbearing age and the elderly (g/dL) was 10.4; 10.39 
and 10.72 respectively and their respective MCV (fL) were 
79.63; 78 and 85 (Table 3).
According to the hemoglobin value, we classify 
anemia as mild, moderate, and severe. In women (general 
and elderly group) and men (general and elderly group), 
mild anemia was predominant (Table 4). As for MCV, in 
the group of women, regardless of age, microcytic anemia 
predominated (52.4%). Among elderly women and men 
(regardless of age group), the most common anemia was 
normocytic (60.5% and 50.5%, respectively) - Table 4. In 
elderly men, this number was 57.1 %.
Of the 456 anemics, the most common etiology was 
iron deficiency (286 patients, 62.7%), followed by anemia 
of inflammation (66 patients, 14.4%). Among those with 
iron deficiency, bleeding totaled 225 cases (78.7%) and 
low intake, 49 cases (17.1%). The main cause of anemia 
in women was iron deficiency, which affected 242 patients 
(68.6%), and the most common site was menorrhagia - 
in 157 women. The main age group for iron deficiency 
etiology was the 40-49 years old. The second most common 
etiology in women was anemia of inflammation (42 cases, 
11.9%) and the main age group with this type of anemia 
was the 70-79 years old (table 5). In the elderly, the main 
etiology found was also iron deficiency in 52 cases (44%), 
and the most common site was the gastrointestinal tract: 
25 cases. Anemia of inflammation came in second with 29 
cases (24.6%) - Table 6.
Table 3: Anemia in the different groups evaluated – n (%)
Women Women in childbearing age Men Elderly
Prevalence of anemia 36.3% 36.3% 22.9% 43.9%
Mean Hb (g/dL) 10.4 10.39 10.92 10.72
Minimum Hb (g/dL) 5.5 5.5 6.0 6.7
Maximum Hb (g/dL) 11.9 11.9 12.9 12.9
Mild Anemia 237 (67.2) 143 (64.7) 69 (67) 88 (74.6)
Moderate Anemia 95 (26.9) 64 (29) 27 (26.2) 25 (21.2)
Severe Anemia 21 (5.9) 14 (6.3) 7 (6.8) 5 (4.2)
Mean MCV (fL) 79.63 78 84.34 85
Microcytic MCV 185 (52.4) 133 (60.2) 36 (35) 38 (32.2)
Normocytic MCV 160 (45.3) 85 (38.4) 52 (50.5) 70 (59.3)
Macrocytic MCV 8 (2.3) 3 (1.4) 15 (14.5) 10 (8.5)
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Table 4: Parameters evaluated in the groups (general and elderly, both by gender) – n (%)
Women Elderly women Men Elderly men
Mild Anemia 237 (67.2) 55 (72.4) 69 (67) 33 (78.6)
Moderate Anemia 95 (26.9) 17 (22.4) 27 (26.2) 8 (19)
Severe Anemia 21 (5.9) 4 (5.2) 7 (6.8) 1 (2.4)
Mean MCV (fL) 79.63 84.48 84.34 85.88
Microcytic MCV 185 (52.4) 25 (32.9) 36 (35) 13 (31)
Normocytic MCV 160 (45.3) 46 (60.5) 52 (50.5) 24 (57.1)
Macrocytic MCV 8 (2.3) 5 (6.6) 15 (14.5) 5 (11.9)
Percentage iron deficiency anemia 68.6% 42.1% 42.7% 47.6%
Percentage anemia of inflammation 11.9% 25% 23.3% 23.8%
Table 5: Cause of anemia in women, by age group – n (%)
Iron deficiency (242 patients) Inflammation (42 patients)
Mean age (years old; y-o) 43.71 60.04
<20 y-o 11 (4.5) 0
20-29 y-o 37 (15.3) 0
30-39 y-o 63 (26) 9 (21.4)
40-49 y-o 66 (27.3) 6 (14.3)
50-59 y-o 31 (12.8) 3 (7.1)
60-69 y-o 8 (3.3) 9 (21.4)
70-79 y-o 12 (5) 10 (23.9)
80-89 y-o 12 (5) 3 (7.1)
>89 y-o 2 (0.8) 2 (4.8)
TOTAL 242 42
Table 6: Cause of anemia in the elderly – n (%)
Iron deficiency (52 patients) Inflammation (29 patients)
Mean age (years old; y-o) 78,76 76,76
All elderly Women Men All elderly Women Men
66-69 y-o 7 (13.5) 6 (18.75) 1 (5) 6 (20.7) 4 (21.1) 2 (20)
70-79 y-o 19 (36.5) 12 (37.5) 7 (35) 15 (51.8) 10 (52.6) 5 (50)
80-89 y-o 21 (40.4) 12 (37.5) 9 (45) 5 (17.2) 3 (15.8) 2 (20)
>89 y-o 5 (9.6) 2 (6.25) 3 (15) 3 (10.3) 2 (10.5) 1 (10)
Total patients by type of anemia 52 32 20 29 19 10
66-75 y-o 19 (36.5) 14 (43.8) 5 (25) 12 (41.4) 9 (47.4) 3 (30)
76-85 y-o 25 (48.1) 15 (46.9) 10 (50) 12 (41.4) 7 (36.8) 5 (50)
>85 y-o 8 (15.4) 3 (9.3) 5 (25) 5 (17.2) 3 (15.8) 2 (20)
Total patients by type of anemia 52 32 20 29 19 10
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DISCUSSION
According to the present study, the prevalence 
of anemia was much higher than that recommended by 
WHO as acceptable (32% vs. 5%)2,21. However, this 
number is close to the Organization’s estimates for Brazil 
(approximately 30%).
We had already expected that because we had 
evaluated a sample of patients in an outpatient clinic 
specific for hematology, there would be a higher value than 
that found in literature, since anemia is the most prevalent 
disease in the specialty. When we compare the data found 
with another study that also evaluated a hematology clinic, 
we see that Rodrigues et al1 identified that 56.7% of the 
patients had anemia. Their rates were probably higher than 
ours because Rodrigues’s is a study of an outpatient clinic 
in the public health system, where often the socioeconomic 
level is lower, which increases the prevalence of anemia.
However, despite this study pointing to a high 
prevalence, it is worth emphasizing that in the total number 
of anemic patients, 67.1% (306 patients) had mild anemia. 
In the subgroups, this percentage of mild anemia was 67.2% 
in women, 64.7% in women of childbearing age and 74.6% 
in the elderly.
In the anemic sample, women are the majority, and 
their prevalence of anemia was 36.3%. If we consider only 
the group of women of childbearing age, this value remains 
the same, being above the general prevalence of this study 
and that recommended by WHO as acceptable. Fabian et 
al.12 found anemia in 19.2% of the women evaluated and the 
most common age group, in that study, was the same found 
by us (the 40-49 years old group), with 21.4% being the 
prevalence in women of childbearing age. Bezerra et al.20 
found a prevalence of 18.6% in women of childbearing age. 
Silla et al.18 showed a prevalence of 36.4% in the women 
studied, a number similar to ours, and the most common 
type was the iron deficiency anemia, also in agreement with 
our data. It is interesting to see how the distribution of the 
etiologies of anemia behaved in women in this study: while 
73.1% of the cases of iron deficiency anemia are in the age 
groups corresponding to the childbearing age, 64.3% of the 
cases of anemia of inflammation are in the age groups after 
this. None of the articles found mentioned the severity of 
anemia regarding the hemoglobin value in women.
In women of childbearing age, there is a high 
demand for iron due to menstrual losses20 and, therefore, 
this group is naturally at risk for the development of anemia, 
of the microcytic type, as found. Thus, due to the possibility 
of individuals in this group becoming pregnant, having 
anemia is even more critical. In the clinical evolution of 
an anemic pregnant woman, the risk of adverse gestational 
outcome is greater, including low birth weight, hence the 
need to reduce the percentage of anemics among women 
of childbearing age4,6.
The prevalence data are even more accentuated in 
our sample when we consider only the elderly, in which the 
prevalence of anemia reached 43.9%, a serious population 
significance according to the WHO criteria. Studies with 
the elderly conducted by Corona et al.10 in the city of 
São Paulo, Sousa et al.26 in the city of Campina Grande 
- Paraíba, Sgnaolin et al.11 in Porto Alegre - Rio Grande 
do Sul and Callera et al.27 in São José dos Campos - São 
Paulo identified a prevalence of anemia in the elderly of 
7.7%, 12.5%, 12.8% and 18.6%, respectively, all of which 
are much lower than the figures in our study. Once again, 
it is important to highlight that those studies were not 
performed in a specific outpatient clinic, like ours, but with 
the general population.
If we divide anemic elderly people by gender, the 
majority were female (76 patients, 64.4%). Their average 
hemoglobin was 10.44 g/dL, while the male was 11.23 g/
dL. Of the studies cited in the previous paragraph, only 
that by Sgnaolin11 found more anemia in women. More 
than 70% of our elderly people presented with mild 
anemia, which agrees with those found by Callera27 and 
Tettamanti25. As for the MCV of the elderly in the present 
study, both male and female, there was predominance of 
normocytic (59.3%), as well as in the studies by Sgnaolin11 
and Tettamanti et al.25. Lacerda et al.28 evaluated an elderly 
population in Diadema - São Paulo - and found, among the 
anemic ones, a slight decrease in hemoglobin and normal 
MCV in most of them. Few previous studies evaluated the 
etiology of anemia. Barbosa et al.24 studied only the elderly 
and found anemia of inflammation as the main etiology, 
which differs from what we have seen, since we identified 
iron deficiency anemia as the most common cause in the 
elderly of both sexes; anemia of inflammation was the 
second cause.
It cannot be overlooked that anemia should not 
be considered a condition resulting from aging16,29. It is 
necessary to look for the cause, remembering that the elderly 
have a higher frequency of chronic and neoplastic diseases, 
which favors the onset of anemia. In the elderly, having 
low hemoglobin worsens their comorbidities, increasing 
mortality27,30. The factor that can justify why the anemia 
rate was higher in the elderly is that, proportionally, we had 
more anemia of inflammation in this group than in others 
(example: the percentage of anemia due to inflammation 
in the elderly was 24.6% and in women 11.9%). 
Considering the average hemoglobin value, both in 
the group of women and in the elderly, a slight decrease in 
the values, 10.4 and 10.72 g/dL, was observed, respectively. 
In women of childbearing age this number was 10.39 g/
dL. In women, due to genital bleeding, MCV was more 
compatible with microcytic anemia than in the elderly 
(52.4% vs 32.9%). Another fact that contributed to this 
finding was that iron deficiency anemia and anemia 
of inflammation had close values in the elderly group, 
which may explain the higher MCV, although considered 
normocytic, in this last group.
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Regarding the most common etiology, iron 
deficiency affected 62.7% of patients. Souza et al.15 also 
found menstrual bleeding in women as the main cause of 
anemia, and gastrointestinal bleeding in the elderly, as in 
this study. As it is a private service, nutritional deficiency 
(17.1% of our cases of iron deficiency anemia) was not 
more prevalent than bleeding, as in other studies carried 
out in Brazil1. Incidentally, since anemia caused by 
nutritional causes is of simpler solution, it would not need 
to be followed up in a specialty clinic, which contributes 
to greater numbers of anemic patients, which may be 
one more explanation for our high prevalence. In this 
study, there was 24.6% of elderly people with anemia of 
inflammation, whereas in women this rate was 11.9%. This 
number reinforces even more, as we have already said, the 
fact that in the elderly the MCV was higher than in women.
CONCLUSION
Our study made it possible to know the reality of the 
patients seen at Clínica Medeiros hematology outpatient 
clinic, drawing an epidemiological profile of anemia and its 
most prevalent causes. Anemic patients are mostly women 
of childbearing age, with mild and microcytic anemia due 
to menstrual bleeding.
Even today, despite numerous health policies 
developed by WHO and other agencies, anemia is a 
highly prevalent disease in Brazil and worldwide. When 
hematology services are considered, these values rise, as 
expected. It is important not to undervalue or trivialize the 
disease, even when mild and oligosymptomatic, given that 
socioeconomic, intellectual, and quality of life losses can 
result from this problem. Not to mention the increase in 
the mortality rate in populations biologically more fragile.
At risk groups, practices that restrict iron and 
vitamin B12 in the diet should be discouraged. In addition, 
blood loss must be screened and treated - the success of 
anemia treatment depends on it.
With this work, we see that anemia, in most cases, is 
a preventable disease, which makes it possible to decrease 
its prevalence in all groups evaluated with early control 
measures of the main etiologies.
It is essential to emphasize in medical training and 
in the education of the general population the importance of 
the topic and the impact that anemia causes on the quality 
of life, so that we begin to seek better results. Knowledge is 
the first step to preventing and providing the best treatment.
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